STATINS PROTECTIVE ROLE IN PATIENTS WITH CHRONIC TOTAL OCCLUSIONS OF CORONARY ARTERIES IN INTRACORONARY INTERVENTIONS

The study objective is evaluate atherosclerosis burden on atorvastatin protective effect in patients with chronic total occlusion recanalization. Methods. 38 patients underwent recanalization of chronic total occlusions. All patients received a loading dose of atorvastatin 80 mg before surgery. Further patients were divided into high and low risk group according to SYNTAX score. In both groups, troponin I, CF fraction of creatine phosphokinase, functional parameters of the myocardium were measured 1 day prior to surgery, 24 hours and 1 month after the surgery. Results. In the high risk group there was discovered more significant troponin I rising compared with low risk group. In the low risk group troponin I level was significantly lower. CF fraction of creatine phosphokinase in both groups was similar. There were no statistically significant changes in echocardiography parameters. Conclusion. Atorvastatin loading dose has a protective effect and prevents periprocedural myocardial ischemia. At the same time this effect appears only in patients with low atherosclerosis burden - SYNTAX score less than 19.5. At the same time it doesn’t influence on central hemodynamics in short-term period.

chronic total occlusion of coronary arteries, atorvastatin, recanalization, percutaneous coronary intervention, SYNTAX Score

1. Fefer P., Knudtson M.L., Cheema A.N., Galbraith P.D., Osherov A.B., Yalonetsky S., Gannot S., Samuel M., Weisbrod M., Bierstone D., Sparkes J.D., Wright G.A., Strauss B.H. Current Perspectives on Coronary Chronic Total Occlusions The Canadian Multicenter Chronic Total Occlusions Registry // Am. Coll. Cardiol. Foundat. 2012. Vol. 59. N 11.

2. Соколов Ю.Н., Соколов М.Ю., Терентьев В.Г., Чубко В.И. ННЦ «Институт Кардиологии им. акад. Н.Д. Стражеско». Перкутанное лечение хронических окклюзий коронарных артерий сердца: морфологические механизмы формирования, отбор пациентов, основные методики лечения // Сучаснi Медичнi Технологii. 2010. № 3.

3. Tajstra M., Pyka Ł., Gorol J., Pres D., Gierlotka M., Gadula-Gacek E., Kurek A., Wasiak M., Hawranek M., Zembala M.O., Lekston A., Poloński L., Bryniarski L., Gąsior M. Impact of Chronic Total Occlusion of the Coronary Artery on Long-Term Prognosis in Patients With Ischemic Systolic Heart Failure // J. Am. Coll. Cardiol. 2016. Vol. 9, N 17.

4. Råmunddal T., Hoebers L., Omerovic E., Henriques P.J., Christian D. Prognostic impact of chronic total occlusion in ischemic heart disease - A report from the Swedish Coronary Angiography and Angioplasty Registry // J. Am. Coll. Cardiol. 2013. October 29.

5. Hoebers L., Råmunddal T., Henriques J.P., Albertsson P., Angerås O., Matejka G., Odenstedt J., Petursson P. Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry // J. Am. Coll. Cardiol. 2013. October 29.

6. Gutierrez-Barrios A., Cañada D., Diaz-Retamino E., Ruiz D., Agarrado A., Gamaza S., Alba M., Otero M.J. Clinival impact of chronic total occlusions in patients undergoing percutaneous coronary intervention of unprotected left main disease // J. Am. Coll. Cardiol. 2016. Vol. 68, N 18, Suppl. B.

7. Christofferson R.D., Lehmann K.G., Martin G.V., Every N., Caldwell J.H., Kapadia S.R. Effect of chronic total coronary occlusion on treatment strategy // Am. J. Cardiol. 2005. May 1. Vol. 95, N 9. P. 1088-1091.

8. Jang W.J., Yang J.H., Choi S.-H., Song Y.B., Hahn J.-Y., Choi J.-H., Kim W.S., Lee Y.T., Gwon H.-C. Revascularization Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion and Well-Developed Collateral Circulation // J. Am. Col. Cardiol. 2015. Vol. 8, No. 2.

9. Maeremans J., Walsh S., Knaapen P., Spratt J.C., Avran A., Hanratty C.G., Faurie B., Agostoni P., Bressollette E., Kayaert P., Bagnall A.J., Egred M., Smith D., Chase A., McEntegart M.B., Smith W., Harcombe A., Kelly P., Irving J., Smith E.J., Strange J.W., Dens J. The Hybrid Algorithm for Treating Сhronic Total Occlusions in Europe. The RECHARGE Registry // J. Am. Coll. Cardiol. 2016. Vol. 68, N 18.

10. Виллер А.Г. Хирургическая эндоваскулярная реканализация венечных артерий и аутовенозных шунтов: дис. … д-ра мед. наук. М., 2007.

11. Показания к реваскуляризации миокарда. Российский согласительный документ. М.: НЦССХ им. А.Н. Бакулева РАМН, 2011. 162 с.

12. Рекомендации ESC/EACTS по реваскуляризации миокарда // Рос. кардиол. журн. 2015. Т. 2, № 118. С. 5-81.

13. Danson E., Sapontis J., Dworakowski R., Webb I., Shah A., Maccarthy P., Hill J., Byrn J. Percutaneous coronary revascularization versus medical therapy in a surgically ineligible cohort // J. Am. Coll. Cardiol. 2016. Vol. 68, N 18, Suppl B.

14. Galassi A.R., Boukhris M., Azzarelli S., Marzà F., Tomasello S.D. Percutaneous Coronary Interventions for Chronic Total Occlusions: More Benefit for the Patient or for the Interventionist’s Ego? // Can. J. Cardiol. 2015. Vol. 31. P. 974-979.

15. Lo N., Michael T.T., Moin D., Patel V.G., Alomar M., Papayannis A., Cipher D., Abdullah S.M., Banerjee S., Brilakis E.S. Periprocedural Myocardial Injury in Chronic Total Occlusion Percutaneous Interventions A Systematic Cardiac Biomarker Evaluation Study // J. Am. Coll. Cardiol. 2014. Vol. 7, N 1.

16. Николаева А.А., Штеренталь И.Ш., Лифшиц Г.И. и др. Особенности нейроэндокринных нарушений регуляции при остром инфаркте миокарда в зависимости от тяжести течения заболевания // Кардиология. 1993. Т. 33, № 11. С. 60-63.

17. Третье универсальное определение инфаркта миокарда. Национальные рекомендации Европейского общества кардиологов // Рос. кардиол. журн. 2013. № 2 (100). Прил. 1.

18. Winchester D.E., Wen X., Xie L., Bavry A.A. Evidence of pre-procedural statin therapy a meta-analysis of randomized trials // J. Am. Coll. Cardiol. 2010. Sep 28, Vol. 56, N 14. P. 1099-1109.

19. Mega S., Patti G., Cannon C.P., Di Sciascio G. Preprocedural statin therapy to prevent myocardial damage in percutaneous coronary intervention: a review of randomized trials // Critical Pathways Cardiol. 2010. Vol. 9, N 1. P. 19-22.

20. Николаева А.А., Николаев К.Ю., Отева Э.А. и др. Диагностические технологии при диспансеризации и первичной профилактике хронических неинфекционных заболеваний // Здравоохранение РФ. 2004. № 2. С. 55-56.

21. Nafasi L., Rahmani R., Shafiee A., Salari A., Abdollahi A., Meysamie A. Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction? // Curr. Med. Research Opinion. 2014 Mar. Vol. 30, N 3. P. 381-386.

22. Sardella G., Lucisano L., Mancone M., Conti G., Calcagno S., Stio R.E., Pennacchi M., Biondi-Zoccai G., Canali E., Fedele F. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial // Int. J. Cardiol. 2013. Oct 9. Vol. 168, N 4. P. 3715-3720.

23. Guo X., Huang X., Wang Q. Effect of intensive pretreatment with atorvastatin calcium on outcomes of percutaneous coronary intervention in elderly patients with coronary heart disease // Nan Fang Yi Ke Da Xue Xue Bao. 2015. Feb. Vol. 35, N 2. P. 295-300.

24. Урванцева И.А., Николаев К.Ю., Милованова Е.В., Воевода М.И. Умеренное и тяжелое поражение коронарного русла по шкале SYNTAX как предиктор осложнений госпитального этапа у пациентов с инфарктом миокарда после эндоваскулярного лечения // Рос. кардиол. журн. 2015. № 3 (119). С. 89-92.

25. Буравихина Т.А. Механизмы нарушения функционального состояния миокарда левого желудочка при хирургическом лечении ишемической болезни сердца: дис. … д-ра мед. наук. М., 2008.

26. Grantham J.A., Marso S.P., Spertus J., House J., Holmes D.R.Jr, Rutherford B.D. Chronic Total Occlusion Angioplasty in the United States // J. Am. Coll. Cardiol. 2009. June. Vol. 2, Iss. 6.

27. Kirschbaum S.W., Baks T., Sianos G., Krestin G.P., Serruys P.W., Feyter P.J., van Geuns R.J. Evaluation of left ventricular function three years after percutaneous recanalization of chronic total coronary occlusions // Am. J. Cardiol. 2008. Jan 15. Vol. 101, N 2. P. 179-185.

28. Prasad A., Rihal C.S., Lennon R.J., Singh M., Jaffe A.S., Holmes D.R. Jr. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients // Circulation: Cardiovasc. Interventions. 2008. Vol. 1, N 1. P. 10-19.

29. Gao Y., Jia Z.-M., Sun Y.-J., Zhang Z.-H., Ren L.-N., Qi G.-X. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome // Chin. Med. J. 2012. Vol. 125, N 13. P. 2250-2254.

30. Auguadro C., Manfredi M., Scalise F., Mortara A., Specchia G. Protective role of chronic statin therapy in reducing myocardial damage during percutaneous coronary intervention // J. Cardiovasc. Med. (Hagerstown). 2006. Jun. Vol. 7, N 6. P. 416-421.

31. Giancarlo M. Myocardial Infarct Size in Patients on Long-Term Statin Therapy Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction // Am. J. Cardiol. 2015. Vol. 116, N 12. P. 1791-1797.